Hawkins M M, Lancashire E R, Winter D L, Frobisher C, Reulen R C, Taylor A J, Stevens M C G, Jenney M
Centre for Childhood Cancer Survivor Studies, Department of Public Health and Epidemiology, University of Birmingham, Edgbaston, Birmingham, UK.
Pediatr Blood Cancer. 2008 May;50(5):1018-25. doi: 10.1002/pbc.21335.
In Britain 75% of individuals diagnosed with childhood cancer survive at least 5 years. The British Childhood Cancer Survivor Study was established to determine the risks of adverse health and social outcomes among survivors. To be eligible individuals were diagnosed with childhood cancer in Britain between 1940 and 1991 and survived at least 5 years. The entire cohort of 17,981 form the basis of population-based studies of late mortality and the risks/causes of second malignant neoplasms using national registration systems.
A postal questionnaire was sent to survivors who were alive and aged at least 16 years via their primary care physician.
Of the 14,836 survivors eligible to receive a questionnaire, 10,483 (71%) returned it completed. Of the 13,211 who were mailed a questionnaire by their primary care physician 10,483 (79%) returned it completed. Outline treatment information concerning initial radiotherapy, chemotherapy and surgery is available.
This is the largest available population-based cohort of childhood cancer survivors to have included investigation of a wide spectrum of adverse outcomes (the risk of which might be increased as a result of childhood cancer or its treatment). The study should provide useful information for counselling survivors, planning long-term clinical follow-up and evaluating the long-term risks likely to be associated with proposed treatment strategies.
在英国,75%被诊断患有儿童癌症的个体至少存活5年。英国儿童癌症幸存者研究旨在确定幸存者中不良健康和社会结局的风险。符合条件的个体是在1940年至1991年期间在英国被诊断患有儿童癌症且至少存活5年的。这17981名个体的整个队列构成了使用国家登记系统进行基于人群的晚期死亡率以及第二种恶性肿瘤的风险/病因研究的基础。
通过其初级保健医生向年龄至少16岁且在世的幸存者发送邮政问卷。
在14836名符合条件可收到问卷的幸存者中,10483名(71%)完成并返回了问卷。在其初级保健医生向其邮寄问卷的13211名幸存者中,10483名(79%)完成并返回了问卷。有关初始放疗、化疗和手术的概要治疗信息是可用的。
这是现有的最大规模的基于人群的儿童癌症幸存者队列,其中包括对广泛不良结局(其风险可能因儿童癌症或其治疗而增加)的调查。该研究应为咨询幸存者、规划长期临床随访以及评估可能与提议的治疗策略相关的长期风险提供有用信息。